Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
09/25/2003 | US20030180256 Cytokine-like proteins |
09/25/2003 | US20030180255 IL-17 homologous polypeptides and therapeutic uses thereof |
09/25/2003 | US20030180225 Walnut and ryegrass allergens |
09/25/2003 | CA2799805A1 Optimizing glycan processing in plants |
09/25/2003 | CA2478294A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
09/25/2003 | CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
09/24/2003 | EP1347048A1 Novel protease |
09/24/2003 | EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
09/24/2003 | EP1346057A2 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family |
09/24/2003 | EP1346056A1 Methods for the production of multimeric proteins, and related compositions |
09/24/2003 | EP1346053A2 Polynucleotides encoding human phosphatases |
09/24/2003 | EP1346052A2 Histone deacetylase-related gene and protein |
09/24/2003 | EP1346045A1 Human protooncogene and protein encoded therein |
09/24/2003 | EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same |
09/24/2003 | EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
09/24/2003 | EP1346039A1 Human cervical cancer 2 protooncogene and protein encoded therein |
09/24/2003 | EP1346032A2 Method for the production of carbohydrates |
09/24/2003 | EP1345969A2 Anti-cd28 antibody |
09/24/2003 | EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
09/24/2003 | EP1345714A1 Genes of corynebacterium |
09/24/2003 | EP1345625A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
09/24/2003 | EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
09/24/2003 | EP1345495A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
09/24/2003 | EP1049709B1 Antimicrobial peptides |
09/24/2003 | EP0985032B1 Ribosome complexes as selection particles for in vitro display and evolution of proteins |
09/24/2003 | CN1444661A Method for detecting growth hormone variations in humans, the variations and their uses |
09/24/2003 | CN1444657A Expression vector using for animal cell |
09/24/2003 | CN1444655A Preparation of recombinant protein in prokaryotic host cell |
09/24/2003 | CN1444603A Low oxygen affinity mutant hemoglobins |
09/24/2003 | CN1444602A Human receptor proteins, related reagents and methods |
09/24/2003 | CN1444599A Novel compounds |
09/24/2003 | CN1444598A Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of immune response to amyloid beta and amyloid deposits |
09/24/2003 | CN1443852A Extraction method of narcissus seed glycopeptide |
09/24/2003 | CN1443778A Monoclonal antibody of melanic related antigen, and its application and medicine composition |
09/24/2003 | CN1443777A Monoclonal antibody capable of identifying tumor cell surface antigen and its preparation and application |
09/24/2003 | CN1443775A Leptospira outer membrane protein and its code sequence |
09/24/2003 | CN1443774A Leptospira hemolysin and its code sequence |
09/24/2003 | CN1443773A Leptospira pathogenic related protein and its code squence |
09/23/2003 | US6624295 Heavy chain and light chain peptides comprising complement determining regions, including single chain FV fragments, used as thrombolytic agents |
09/23/2003 | US6624143 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
09/23/2003 | US6623980 Mixing polypeptides with exogeneous proteins, oligopeptides, polysaccharides or polynucleotides, then analyzing binding; medical diagnosis and therapy |
09/23/2003 | US6623957 Immunotherapy for T-cell mediated autoimmune disease |
09/23/2003 | US6623940 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
09/23/2003 | US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same |
09/23/2003 | US6623934 For isolation of proteins that may be used to induce bone and/or cartilage or other connective tissue formation, and in wound healing and tissue repair |
09/23/2003 | US6623925 Screening for a test compound that affects the ability of DNA to bind to protein or affects the expression of reporter molecule; use for gene therapy |
09/23/2003 | US6623738 Polypeptide consisting of amino acid sequence 2 or 4 which is not cross reactive with mouse, chick nor drosophila neuro-pilin-1 |
09/23/2003 | CA2147482C Process for manufacturing crystals of growth hormone and crystals thereby obtained |
09/23/2003 | CA2139518C Antigenic regions of tlp complexes and antibodies against the same |
09/23/2003 | CA2082424C Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
09/18/2003 | WO2003076643A2 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
09/18/2003 | WO2003076610A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
09/18/2003 | WO2003076571A2 Cancer-linked gene as target for chemotherapy |
09/18/2003 | WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
09/18/2003 | WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
09/18/2003 | WO2003076473A1 Specific ab1'-antibodies against tumour-associated antigen ca 125 |
09/18/2003 | WO2003076470A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins |
09/18/2003 | WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature |
09/18/2003 | WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
09/18/2003 | WO2003060068A3 Oxa1p enhanced protein secretion |
09/18/2003 | WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
09/18/2003 | WO2003038443A3 Noe-nmr based methods for the identifycation of compounds which can bind to membrane receptors |
09/18/2003 | WO2003038082A3 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
09/18/2003 | WO2003008441A3 Moringa seed proteins |
09/18/2003 | WO2002099382A3 Multiplexing method |
09/18/2003 | WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
09/18/2003 | WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
09/18/2003 | WO2002077174A3 Human cytokine receptor |
09/18/2003 | WO2002066646A3 Neurotransmission-associated proteins |
09/18/2003 | WO2002059308A3 Method of diagnosing and treating cartilage disorders |
09/18/2003 | WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease |
09/18/2003 | WO2002036625A9 Prokineticin polypeptides, related compositions and methods |
09/18/2003 | US20030177512 Interference with coding sequence of target genes; transgenic animals; insertion of stem cell into embryo |
09/18/2003 | US20030177511 Antitumor, anticancer agents |
09/18/2003 | US20030177508 Elongase genes and uses thereof |
09/18/2003 | US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease |
09/18/2003 | US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
09/18/2003 | US20030176673 Fermentation of fusion protein; genetic engineering |
09/18/2003 | US20030176666 Hypothalamus-specific polypeptides |
09/18/2003 | US20030176659 Adipocyte-specific protein homologs |
09/18/2003 | US20030176658 Adipocyte-specific protein homologs |
09/18/2003 | US20030176655 Genetic engineering; cardiovascular disorders |
09/18/2003 | US20030176652 Human and mouse beta-defensins, antimicrobial peptides |
09/18/2003 | US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
09/18/2003 | US20030176649 Genetic engineering; cardiovascular disorders; antiischemic agents; antitumor agents; vision disorders; antiarthritic agents |
09/18/2003 | US20030176648 Ion channel |
09/18/2003 | US20030176647 Antibodies to OCIF-binding molecules |
09/18/2003 | US20030176644 Compositions and methods for molecular biology |
09/18/2003 | US20030176387 Regulation of human pyroglutamyl peptidase-like enzyme |
09/18/2003 | US20030176355 Administering protein and biologically active substance; formulation acquires a non-liquid form under physiological conditions and biologically active substance is delivered from non-liquid to localized site |
09/18/2003 | US20030176349 Stable hypoxia inducible factor-1 alpha and method of use |
09/18/2003 | US20030176348 For use as therapeutic agent for a syndrome resembling premature aging, a therapeutic agent for adult diseases or an aging-suppressing agent |
09/18/2003 | US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent |
09/18/2003 | US20030176340 For therapy of renal failure |
09/18/2003 | US20030176339 For therapy and prophylaxis of diabetes, obesity, arteriosclerosis, hyperlipemia, hypertriglyceridemia, hypo-high density lipoproteinemia, hypoapolipoproteinemia A-I or nervous disorders |
09/18/2003 | US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
09/18/2003 | US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer |
09/18/2003 | US20030176330 55562 and 21617, novel human proteins and methods of use thereof |
09/18/2003 | US20030175996 Peptide fructose and complex thereof with binding protein |
09/18/2003 | US20030175995 Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |